Cardiovascular health helps protect the cardiovascular system by reducing oxidative stress, improving blood vessel function, and preventing the oxidation of LDL (bad) cholesterol, which can contribute to heart disease
Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly GLP1 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
The pivotal GLP-1 trials the ones generating the headline weight loss numbers were run mostly in younger, premenopausal participants
Research published in Diabetes, Obesity and Metabolism has demonstrated correlations between improvements in insulin resistance with GLP-1 receptor agonists and reductions in hepatic fat content, as measured by magnetic resonance imaging
Emma appreciated the ongoing support from Harper Meds
de Alwis, R